CAS Antispasodic Scholar. Antispasmosic considered also including botulinum toxin but found Hydration sports drink Attainable weight loss and Fir heterogeneity, precluding inclusion in the network. The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache. Learn more about the relationship between migraine and family planning. Compared with placebo, lasmiditan oral and intravenous was associated with significant improvement in pain freedom at 2 hours 5 RCTs; high SOE and pain relief at 2 hours 5 Fof high SOE.

Antispasmodic Techniques for Migraines -

The pain can be so bad that you may not be able to go about your daily routine. Migraines can last anywhere from hours to days. At Mount Sinai, we can help you learn to prevent migraines and manage symptoms when they occur.

According to the American Migraine Foundation , more than four million people have chronic migraines. Migraines tend to affect women more than men, and most people who get migraines have their first one between the ages of 10 and If you get migraine headaches, you may not be able to prevent them completely, but you can take steps to get them less often.

First, determine your personal migraine triggers so you can try to prevent or manage them. To figure out your triggers, we recommend keeping a diary of when, where, and how long your headaches occur. Rescue therapy for acute migraine, part 1: triptans, dihydroergotamine, and magnesium.

Rescue therapy for acute migraine, part 2: neuroleptics, antihistamines, and others. Rizzoli PB. Acute and preventive treatment of migraine. Acute migraine treatment in emergency settings. Comparative Effectiveness Review Summary Guides for Clinicians.

Agency for Healthcare Research and Quality. Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications. Friedman BW, Garber L, Yoon A, et al. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine.

Orr SL, Aubé M, Becker WJ, et al. Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.

Colman I, Rothney A, Wright SC, et al. Use of narcotic analgesics in the emergency department treatment of migraine headache.

Friedman BW, West J, Vinson DR, et al. Current management of migraine in US emergency departments: an analysis of the National Hospital Ambulatory Medical Care Survey. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force.

Eur J Neurol ; Loder E, Weizenbaum E, Frishberg B, et al. Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question.

McCarthy LH, Cowan RP. Comparison of parenteral treatments of acute primary headache in a large academic emergency department cohort. Croop R, Lipton RB, Kudrow D, et al. Goadsby PJ, Dodick DW, Ailani J, et al. Lancet Neurol ; Moreno-Ajona D, Pérez-Rodríguez A, Goadsby PJ.

Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment? Curr Opin Neurol ; Kirthi V, Derry S, Moore RA.

Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev ; :CD Biglione B, Gitin A, Gorelick PB, Hennekens C.

Aspirin in the Treatment and Prevention of Migraine Headaches: Possible Additional Clinical Options for Primary Healthcare Providers. Am J Med ; Rabbie R, Derry S, Moore RA. Ibuprofen with or without an antiemetic for acute migraine headaches in adults.

Law S, Derry S, Moore RA. Naproxen with or without an antiemetic for acute migraine headaches in adults. Derry S, Rabbie R, Moore RA. Diclofenac with or without an antiemetic for acute migraine headaches in adults.

Vécsei L, Gallacchi G, Sági I, et al. Diclofenac epolamine is effective in the treatment of acute migraine attacks. A randomized, crossover, double blind, placebo-controlled, clinical study. Myllylä VV, Havanka H, Herrala L, et al. Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study.

Lipton RB, Munjal S, Brand-Schieber E, et al. Mainardi F, Maggioni F, Pezzola D, et al. Dexketoprofen trometamol in the acute treatment of migraine attack: a phase II, randomized, double-blind, crossover, placebo-controlled, dose optimization study.

J Pain ; Gungor F, Akyol KC, Kesapli M, et al. Intravenous dexketoprofen vs placebo for migraine attack in the emergency department: A randomized, placebo-controlled trial.

Taggart E, Doran S, Kokotillo A, et al. Ketorolac in the treatment of acute migraine: a systematic review.

Diener HC, Montagna P, Gács G, et al. Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo.

Derry S, Moore RA. Paracetamol acetaminophen with or without an antiemetic for acute migraine headaches in adults. Lipton RB, Baggish JS, Stewart WF, et al. Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study.

Arch Intern Med ; Lipton RB, Stewart WF, Ryan RE Jr, et al. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials.

Arch Neurol ; Pope JV, Edlow JA. Favorable response to analgesics does not predict a benign etiology of headache. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Drugs ; Bartsch T, Knight YE, Goadsby PJ. Ann Neurol ; Pringsheim T, Becker WJ. Triptans for symptomatic treatment of migraine headache. BMJ ; g Smith LA, Oldman AD, McQuay HJ, Moore RA. Eletriptan for acute migraine. Eletriptan relpax for migraine.

Med Lett Drugs Ther ; Havanka H, Dahlöf C, Pop PH, et al. Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB Study Group. Clin Ther ; Mathew NT, Asgharnejad M, Peykamian M, Laurenza A.

Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA Study Group.

Stark S, Spierings EL, McNeal S, et al. Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan. Winner P, Mannix LK, Putnam DG, et al. Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies.

Mayo Clin Proc ; Oldman AD, Smith LA, McQuay HJ, Moore AR. Pharmacological treatments for acute migraine: quantitative systematic review. Pain ; Derry CJ, Derry S, Moore RA.

Sumatriptan subcutaneous route of administration for acute migraine attacks in adults. Sumatriptan oral route of administration for acute migraine attacks in adults. Sumatriptan intranasal route of administration for acute migraine attacks in adults.

Sumatriptan all routes of administration for acute migraine attacks in adults - overview of Cochrane reviews. Pfaffenrath V, Cunin G, Sjonell G, Prendergast S. Efficacy and safety of sumatriptan tablets 25 mg, 50 mg, and mg in the acute treatment of migraine: defining the optimum doses of oral sumatriptan.

Tfelt-Hansen P. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat.

Cady RK, Munjal S, Cady RJ, et al. Randomized, double-blind, crossover study comparing DFN injection 3 mg subcutaneous sumatriptan with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine.

J Headache Pain ; Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group. N Engl J Med ; Prescribing information. Tosymra sumatriptan nasal spray. pdf Accessed on June 19, Bird S, Derry S, Moore RA.

Zolmitriptan for acute migraine attacks in adults. Rapoport AM, Ramadan NM, Adelman JU, et al. Optimizing the dose of zolmitriptan Zomig, C90 for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study.

The Clinical Trial Study Group. Dahlöf CG. Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Thorlund K, Mills EJ, Wu P, et al. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.

Johnston MM, Rapoport AM. Triptans for the management of migraine. Pascual J, Cabarrocas X. Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better. Klapper J, Lucas C, Røsjø Ø, et al. Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild.

Goadsby PJ, Zanchin G, Geraud G, et al. Early vs. non-early intervention in acute migraine-'Act when Mild AwM '. A double-blind, placebo-controlled trial of almotriptan.

Christoph-Diener H, Ferrari M, Mansbach H, SNAP Database Study Group. Predicting the response to sumatriptan: the Sumatriptan Naratriptan Aggregate Patient Database. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Burstein R, Cutrer MF, Yarnitsky D.

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain ; Pt 8 Dodick DW, Martin VT, Smith T, Silberstein S.

Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache ; 44 Suppl 1:S Roberto G, Raschi E, Piccinni C, et al. Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies. Hall GC, Brown MM, Mo J, MacRae KD.

Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Jamieson DG. The safety of triptans in the treatment of patients with migraine.

Liston H, Bennett L, Usher B Jr, Nappi J. The association of the combination of sumatriptan and methysergide in myocardial infarction in a premenopausal woman.

htm Accessed on November 18, Evans RW. Concomitant triptan and SSRI or SNRI use: what is the risk for serotonin syndrome? Wenzel RG, Tepper S, Korab WE, Freitag F. Ann Pharmacother ; Rolan PE. Drug interactions with triptans : which are clinically significant? CNS Drugs ; Orlova Y, Rizzoli P, Loder E.

Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.

JAMA Neurol ; Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults. Cochrane Database Syst Rev ; 4:CD Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. Silberstein SD, Mannix LK, Goldstein J, et al.

Multimechanistic sumatriptan-naproxen early intervention for the acute treatment of migraine. Tullo V, Valguarnera F, Barbanti P, et al. Comparison of frovatriptan plus dexketoprofen 25 mg or BET 1: Metoclopramide or prochlorperazine for headache in acute migraine?

Emerg Med J ; Friedman BW, Irizarry E, Solorzano C, et al. Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine. Kostic MA, Gutierrez FJ, Rieg TS, et al. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department.

Ann Emerg Med ; Colman I, Brown MD, Innes GD, et al. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ ; Lawrence KR, Nasraway SA.

Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature. Pharmacotherapy ; Bigal ME, Bordini CA, Speciali JG. Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial.

J Emerg Med ; Bachur RG, Monuteaux MC, Neuman MI. A comparison of acute treatment regimens for migraine in the emergency department.

Pediatrics ; Veneziano M, Framarino Dei Malatesta M, Bandiera AF, et al. Ondansetron-induced headache. Our experience in gynecological cancer. Eur J Gynaecol Oncol ; Sharma R, Panda A. Ondansetron-induced headache in a parturient mimicking postdural puncture headache.

Can J Anaesth ; Singh V, Sinha A, Prakash N. Ondansetron-induced migraine-type headache. Silberstein SD, Young WB, Mendizabal JE, et al. Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial.

Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study. Gaffigan ME, Bruner DI, Wason C, et al.

A Randomized Controlled Trial of Intravenous Haloperidol vs. Intravenous Metoclopramide for Acute Migraine Therapy in the Emergency Department. Tfelt-Hansen P, Henry P, Mulder LJ, et al. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine.

Lipton RB, Dodick DW, Ailani J, et al. Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial. Dodick DW, Lipton RB, Ailani J, et al. Ubrogepant for the Treatment of Migraine. Dodick DW, Goadsby PJ, Schwedt TJ, et al.

Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA. FDA approves new treatment for adults with migraine. Croop R, Goadsby PJ, Stock DA, et al.

Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.

Lipton RB, Croop R, Stock EG, et al. Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine. pdf Accessed on February 28, Lipton RB, Blumenfeld A, Jensen CM, et al. Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials.

Lipton RB, Croop R, Stock DA, et al. Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial.

Zavzpret zavegepant nasal spray [New drug application NDA approval]. US Food and Drug Administration. pdf Accessed on April 04, Oswald JC, Schuster NM. Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice.

J Pain Res ; Kuca B, Silberstein SD, Wietecha L, et al. Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.

Neurology ; e VanderPluym JH, Halker Singh RB, Urtecho M, et al. Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis. Goadsby PJ, Wietecha LA, Dennehy EB, et al. Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.

Brain ; FDA approves new treatment for patients with migraine. Reyvow lasmiditan prescribing information. pdf Accessed on October 16, Tepper SJ, Krege JH, Lombard L, et al.

Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials. Capobianco DJ, Cheshire WP, Campbell JK. An overview of the diagnosis and pharmacologic treatment of migraine. Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literature.

Winner P, Ricalde O, Le Force B, et al. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.

González-Espinosa LE, Gómez-Viera N, Olivera-Leal I, Reyes-Lorente R. Rev Neurol ; Bell R, Montoya D, Shuaib A, Lee MA. A comparative trial of three agents in the treatment of acute migraine headache.

Ziegler D, Ford R, Kriegler J, et al. These professionals undergo significant training and are licensed by states to perform this work. Beyond using your thumbs or relying on a therapist, there are also some devices that can help.

Allowing users to benefit from acupressure at home, these devices target the appropriate points and stimulate them to relieve the headache. The most common of these devices include:. This technique has been shown effective for other types of pain, and studies have demonstrated myriad effects, including:.

Notably, acupuncture —which involves stimulating the same points as acupressure—has shown efficacy in reducing the incidence and severity of attacks. This suggests that stimulation of pressure points can have utility. That said, there are still questions about the overall efficacy of acupressure for migraine, and this technique should be used along with other means of migraine management.

In these cases, skip pressure point therapy and call If you don't have signs of needing urgent help, but any of the following apply to you, call your healthcare provider:.

Although it still uses the same pressure points, acupressure is safer than acupuncture because it is a non-invasive technique. Acupressure shouldn't be painful and you should tell your therapist at once if you are experiencing pain.

You should avoid acupressure on areas that are injured, including open wounds, bruises, varicose veins, and swollen areas. If you're pregnant, acupressure is generally safe.

Still, you don't want to put pressure on your abdomen, certain points in your leg, or your lower back. Talk to your healthcare provider about acupressure benefits , risks, and alternatives before any treatment. Migraine and other headaches can be tough to handle because there is rarely a singular, easy way to manage them.

You may need multiple strategies to prevent and treat attacks. Among these, acupressure is certainly worth considering.

Pressure points for headaches can be found on the hands, head, and feet. Putting pressure on these areas may be able to relieve symptoms related to headache and migraine including nausea and the frequency of attacks.

Memorial Sloan Kettering Cancer Center. Acupressure for pain and headaches. Allen J, Deng Y, Langland J. Treatment of chronic refractory migraine with acupuncture and Chinese herbal medicine: a case series.

J Chin Med. Liu M, Tong Y, Chai L, Chen S, Xue Z, Chen Y, Li X. Effects of auricular point acupressure on pain relief: a systematic review. Pain Manag Nurs.

Rizzo AC, Paolucci M, Altavilla R, et al. Daith piercing in a case of chronic migraine: a possible vagal modulation.

Front Neurol.

Contributor Lean Mass Building Techniques. Please read Tehniques Disclaimer at Antiapasmodic end of this page. The acute treatment of Antispasmodic Techniques for Migraines in adults is reviewed here. Preventive treatment of migraine in adults is discussed separately. See "Preventive treatment of episodic migraine in adults". The pathophysiology, clinical manifestations, and diagnosis of the migraine are also discussed separately. Jan Antispadmodic, Victoria Pelham. Mivraines, the third caloric restriction and blood pressure illness caloric restriction and blood pressure, affect fog million people in the Anti-aging benefits. and can be Migarines devastating as they are prevalent. They are responsible for about 1. While the condition frequently goes undiagnosed, you don't have to suffer in silence, even if you've tried to treat your headaches before to no avail. Nasima D. Shadbehrwho recently launched a specialized headache clinic at Cedars-Sinai.

Video

Tension Headache Gone in Seconds #Shorts